Medicines Not Working? There’s An App For That
Roche Diabetes Candidate Meets Goals of Five Trials
FDA Approves Benicar For The Treatment Of High Blood Pressure in Children and Adolescents aged 6-16
Read the rest of this entry »
THE LATEST WORD
Top Industry Stories – February 11, 2010
Posted on February 11th, 2010 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industy Stories 2.10.10
Posted on February 10th, 2010 | by Rxmedyn | No Comments »Usana 4Q profit doubles on lower general costs (Associated Press)
GSK reveals plans to trim workforce at UK research site (Pharmatimes.com)
Sanofi-Aventis Q4 Profit Up on Swine Flu Vaccines (Associated Press)
Blow for Novartis and B-MS as NICE rejects Afinitor, Tasigna and Sprycel (Pharmatimes.com)
Posted in Industry Stories, Uncategorized
Top Industry Stories – 2.9.10
Posted on February 9th, 2010 | by Rxmedyn | No Comments »Emerging social network Foursquare plans to launch a partnership with Zagat (PR Week) Read the rest of this entry »
Takeda Launches Osteosarcoma Medicine Mepact in EU (Oncology Weekly)
FDA OK’s Wider Use of AstraZeneca’s Crestor (PharmaTimes)
Novartis buys rights to Debiopharm’s “Hep C” drug (PharmaTimes)
Posted in Industry Stories, Uncategorized
Top Industry Stories – February 8, 2010
Posted on February 8th, 2010 | by Rxmedyn | No Comments »Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration (PR Newswire)
Pfizer To Sell Viagra In Israel Via Internet (Globe Newswire)
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial (BusinessWire)
Vertex Remains On Track With Telaprevir For 2010 NDA, 2011 Anticipated Launch (Health News Daily)
Posted in Industry Stories
Top Industry Stories – February 5, 2010
Posted on February 5th, 2010 | by Rxmedyn | No Comments »- Glaxo to Close Italy R&D Center, Affecting 500 Jobs, Unions Say (Bloomberg)
- QIAGEN Unit and Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (MarketWatch)
- PREVIEW-Sanofi Q4 Seen Up, Cautious for 2010 (Reuters)
- EC Changes on Running Pharma Must Not be Cosmetic – DTB (PharmaTimes)
Posted in Industry Stories
Top Industry Stories – February 4, 2010
Posted on February 4th, 2010 | by Rxmedyn | No Comments »- Glaxo Plans More Savings as Flu Windfall Dwindles (Reuters)
- Pfizer Misses Estimates, and Shares Slide (The New York Times)
- Allergan 4Q Profit Rises 51%; Sees Weak 1Q Earnings (The Wall Street Journal)
- EU “Pushing” India Over Generics in “Secret” Trade Talks (PharmaTimes)
Posted in Industry Stories
Top Industry Stories – February 3, 2010
Posted on February 3rd, 2010 | by Rxmedyn | No Comments »- Pfizer profit misses; 2010 outlook below Street (Reuters)
- Now It’s Actavis vs Teva in Fight for Ratiopharm – Report (PharmaTimes)
- Roche FY Net Profit Down 22 Percent on Genentech Costs (PharmaLive)
- FDA Requests $4.03 Billion to Promote and Protect Public Health (World Pharma News)
Posted in Industry Stories
Top Industry Stories – February 2, 2010
Posted on February 2nd, 2010 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – February 1, 2010
Posted on February 1st, 2010 | by Rxmedyn | No Comments »- Pfizer: Expects to be No.1 in Japan Generic Drugs (Reuters)
- Drug giants seek help to cut costs (PharmacyEurope)
- AstraZeneca to Cut 8000 Pharmaceutical Jobs (Pharmaceutical Jobs)
- GSK Silent on Job Cut Rumors, New Tykerb OK (PharmaTimes)
Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics